Phase 3
Completed N=360
Comparing Tissue Adhesives in Port Site Closure
Dermatitis, Contact
Source: ClinicalTrials.gov NCT05492721 ↗
Enrolled (actual)
360
Serious AEs
0.0%
Results posted
May 2026
Primary outcomePrimary: Number of Participants Who Develop Contact Dermatitis — 21; 18 Participants
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
This is a multi-center randomized controlled trial to evaluate two different methods of reinforcing surgical port site closure: 2-Octylcyanoacrylate and n-butyl-2-cyanoacrylate.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Develop Contact Dermatitis |
21; 18 | — |
| SECONDARY Mean Diameter of Erythema |
— | — |
| SECONDARY Number of Participants With Wound Dehiscence |
0; 0 | — |
| SECONDARY Number of Participants With Surgical Site Infection |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- 18 or older
- undergoing an elective laparoscopic or robotic abdominal surgery
Exclusion Criteria
- Patients unlikely to follow-up (live out of state, unable to be reached by phone or email)
- Patients with a known allergy to 2-Octylcyanoacrylate or N-butyl-2-cyanoacrylate.
Data sourced from ClinicalTrials.gov (NCT05492721). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.